Are you Dr. Relkin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
428 E 72nd St Ofc 500
New York, NY 10021Phone+1 212-746-2441Fax+1 212-746-5584- Is this information wrong?
Summary
- Dr. Norman Relkin, MD is a board certified neurologist in New York, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor of Neurology at Cornell Univ-Weill Medical College.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1988 - 1991- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1987 - 1988
Albert Einstein College of MedicineClass of 1987
Certifications & Licensure
NY State Medical License 1991 - 2016- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Join now to see all
Clinical Trials
- Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease Start of enrollment: 2006 Feb 01
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease Start of enrollment: 2008 Dec 19
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Publications & Presentations
PubMed
- 14 citationsComparison of saliva and nasopharyngeal swab SARS-CoV-2 RT-qPCR testing in a community setting.Monique Torres, Katherine Collins, Mariah Corbit, Maureen Ramirez, Caroline Riley Winters, Lily Katz, Morgan Ross, Norman Relkin, Wenli Zhou> ;The Journal of Infection. 2021 Apr 1
- 23 citationsThe clinical spectrum of hydrocephalus in adults: report of the first 517 patients of the Adult Hydrocephalus Clinical Research Network registry.Michael A. Williams, Sean J. Nagel, Mark G. Luciano, Norman R. Relkin, Thomas J. Zwimpfer, Heather Katzen, Richard Holubkov, Abhay Moghekar, Jeffrey H. Wisoff, Guy M. ...> ;Journal of Neurosurgery. 2020 Jun 1
- 45 citationsSalmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli.Sarah A. Tursi, Rama Devudu Puligedda, Paul Szabo, Lauren K. Nicastro, Amanda L. Miller, Connie Qiu, Stefania Gallucci, Norman R. Relkin, Bettina A. Buttaro, Scott K. ...> ;Nature Communications. 2020 Feb 21
- Join now to see all
Press Mentions
Anavex Life Sciences : CORPORATE PRESENTATION FEBRUARY 2021March 1st, 2021
Anavex Soars on Positive Alzheimer’s ResultsJanuary 11th, 2016
'Medical Marijuana' Pill Falls Short in Dementia Study - US NewsMay 13th, 2015- Join now to see all
Grant Support
- Intravenous Immunoglobulin (IVIG) For Treatment Of AD (IVIG)National Institute On Aging2006–2010
- Phase II Study Of IVIG For Alzheimer'S DiseaseNational Center For Research Resources2006–2007
- Risk Evaluation And Education For Alzheimer'S Disease (Reveal Ii)National Center For Research Resources2004–2007
- Effect Of IVIG Dose On Anti-Amyloid Beta Antibody And Amyloid Beta Peptide BloodNational Center For Research Resources2006
